Novan Therapeutics Obtains $50,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4c8879da-b9ad-4dd7-bff9-a224ee0d26b6
Date
3/31/2015
Company Name
Novan Therapeutics
Mailing Address
4222 Emperor Boulevard Durham, NC 27703 USA
Company Description
Novan uses a licensed nitric oxide technology, developed at the lab of Schoenfisch, to give medical devices an antimicrobial coating, helping to fight bacteria.
Website
http://www.novantherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$50,000,000
Transaction Round
Undisclosed
Proceeds Purposes
The funds secured will support Novan’s efforts to create impactful, first-in-class, nitric oxide-based healthcare solutions in a number of large market indications.
M&A Terms
Venture Investor
Venture Investor